JP2009505945A5 - - Google Patents

Download PDF

Info

Publication number
JP2009505945A5
JP2009505945A5 JP2008513710A JP2008513710A JP2009505945A5 JP 2009505945 A5 JP2009505945 A5 JP 2009505945A5 JP 2008513710 A JP2008513710 A JP 2008513710A JP 2008513710 A JP2008513710 A JP 2008513710A JP 2009505945 A5 JP2009505945 A5 JP 2009505945A5
Authority
JP
Japan
Prior art keywords
phenyl
evaporation
fast
composition
substantially pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009505945A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020256 external-priority patent/WO2006127909A2/en
Publication of JP2009505945A publication Critical patent/JP2009505945A/ja
Publication of JP2009505945A5 publication Critical patent/JP2009505945A5/ja
Pending legal-status Critical Current

Links

JP2008513710A 2005-05-26 2006-05-25 (s)−1−シアノブタン−2−イル(s)−1−(3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)フェニル)エチルカルバメートの多形形態 Pending JP2009505945A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68464405P 2005-05-26 2005-05-26
PCT/US2006/020256 WO2006127909A2 (en) 2005-05-26 2006-05-25 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate

Publications (2)

Publication Number Publication Date
JP2009505945A JP2009505945A (ja) 2009-02-12
JP2009505945A5 true JP2009505945A5 (cg-RX-API-DMAC10.html) 2009-07-09

Family

ID=37076080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513710A Pending JP2009505945A (ja) 2005-05-26 2006-05-25 (s)−1−シアノブタン−2−イル(s)−1−(3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)フェニル)エチルカルバメートの多形形態

Country Status (8)

Country Link
US (2) US7504515B2 (cg-RX-API-DMAC10.html)
EP (1) EP1902040A2 (cg-RX-API-DMAC10.html)
JP (1) JP2009505945A (cg-RX-API-DMAC10.html)
CN (1) CN101223150B (cg-RX-API-DMAC10.html)
AU (1) AU2006249921A1 (cg-RX-API-DMAC10.html)
CA (1) CA2609511A1 (cg-RX-API-DMAC10.html)
NZ (1) NZ564252A (cg-RX-API-DMAC10.html)
WO (1) WO2006127909A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009505945A (ja) 2005-05-26 2009-02-12 バーテックス ファーマシューティカルズ インコーポレイテッド (s)−1−シアノブタン−2−イル(s)−1−(3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)フェニル)エチルカルバメートの多形形態
WO2015102019A2 (en) * 2013-12-30 2015-07-09 Msn Laboratories Private Limited Process for the preparation of polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-piperazinyl]-2-benzofuran carboxamide hydrochloride
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301802B6 (cs) * 1999-03-19 2010-06-30 Vertex Pharmaceuticals Incorporated Deriváty mocoviny jako inhibitory IMPDH a farmaceutické prostredky s jejich obsahem
US7943593B2 (en) * 2002-12-06 2011-05-17 Vertex Pharmaceuticals Incorporated Compositions comprising inhibitors of IMPDH enzyme
JP2009505945A (ja) 2005-05-26 2009-02-12 バーテックス ファーマシューティカルズ インコーポレイテッド (s)−1−シアノブタン−2−イル(s)−1−(3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)フェニル)エチルカルバメートの多形形態

Similar Documents

Publication Publication Date Title
JP2025176008A5 (cg-RX-API-DMAC10.html)
RU2466129C2 (ru) Твердые формы рацемического илапразола
JP2023519891A5 (cg-RX-API-DMAC10.html)
RU2008143362A (ru) Сокристаллическая форма производного с-гликозида c l-пролином
JP2010535742A5 (cg-RX-API-DMAC10.html)
JP2011514380A5 (cg-RX-API-DMAC10.html)
JP2009520690A5 (cg-RX-API-DMAC10.html)
JP2007532560A5 (cg-RX-API-DMAC10.html)
JP2009514798A5 (cg-RX-API-DMAC10.html)
TW200927125A (en) Salt form
JP2020514291A5 (cg-RX-API-DMAC10.html)
RU2013101580A (ru) Кристаллическая форма бензил-бензольного ингибитора sglt
TW200829574A (en) Renin inhibitors and method of use thereof
HRP20171511T1 (hr) Ivabradin-hidroklorid, oblik iv
JP2014510746A5 (cg-RX-API-DMAC10.html)
JP2020536893A5 (cg-RX-API-DMAC10.html)
JP2009534373A5 (cg-RX-API-DMAC10.html)
JP2013520488A5 (cg-RX-API-DMAC10.html)
JP2016510767A5 (cg-RX-API-DMAC10.html)
US11161803B2 (en) Ammonium carboxylate compound, crystalline form, amorphous form and preparation method thereof
CA3133415C (en) Crystal form a of 2'-fluoro-4'-substituted nucleoside analog i and preparation method therefor and use thereof
CN109476624A (zh) 钠-葡萄糖协同转运蛋白2抑制剂的晶型
CA2553345A1 (en) Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
RU2007143025A (ru) Полиморфизм додекагидроклопента[а]фенантренилового эфира тиофенкарбоновой кислоты
JP2008530090A5 (cg-RX-API-DMAC10.html)